Core Viewpoint - OSR Holdings, Inc. is hosting a Virtual Investor Event on August 6, 2025, to provide updates on its strategic direction, subsidiary performance, capital allocation, and R&D pipeline [1][2]. Event Details - Date: August 6, 2025 [3] - Time: 8:00 a.m. ET / 2:00 p.m. CEST / 9:00 p.m. KST [3] - Location: Virtual (livestream access) [3] - Registration opens on August 4, 2025 [3] - Replay available post-event on the Investor Relations website [3] Agenda Highlights - The event will feature updates on subsidiary and R&D pipeline, including: - Vaximm: Antigen-specific in vivo T-cell Immunotherapies [7] - Darnatein: DRT101, a DMOAD candidate [7] - Woori IO acquisition: Noninvasive CGM opportunity [7] - Equity Line of Credit (ELOC) financing strategy [7] - Blockchain & Tokenization strategy [7] - Live Q&A with management [7] Company Overview - OSR Holdings, Inc. is a global healthcare holding company focused on biomedical innovations to enhance health and wellness [5]. - The company operates in immuno-oncology, regenerative biologics, and medical device distribution [5]. - OSR's vision includes acquiring and operating innovative healthcare companies to improve patient care through advanced R&D [5].